SMTL ID : 3ij9.1

Directed 'in situ' Elongation as a Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic a-Amylase

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 1.85 Å
Oligo State
monomer
Ligands
1 x B9D: (2R,3R,4R,5S,6R)-6-fluoranyl-6-(hydroxymethyl)oxane-2,3,4,5-tetrol(Post Translational Modification)
1 x BGC: BETA-D-GLUCOSE(Non-covalent)
2 x B0D: (2R,3S,4R,5R,6R)-2,6-difluoro-2-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol(Non-covalent)
1 x CA: CALCIUM ION(Non-covalent)
1 x CL: CHLORIDE ION(Non-functional Binders)
Links
RCSB   PDBe   PDBj   PDBsum   CATH   PLIP
Citation
Zhang, R. et al., Directed "in situ" inhibitor elongation as a strategy to structurally characterize the covalent glycosyl-enzyme intermediate of human pancreatic alpha-amylase. Biochemistry (2009)
Release Date
2009-10-27
Peptides
Pancreatic alpha-amylase: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

Pancreatic alpha-amylase

Related Entries With Identical Sequence

1bsi.1 | 1cpu.1 | 1hny.1 | 1u2y.1 | 1u30.1 | 1u33.1 | 1xcw.1 | 1xcx.1 | 1xd0.1 | 1xd1.1 | 2qmk.1 | 2qv4.1 | 3bai.1 | 3baj.1 | 3baw.1 | 3ij7.1 | 3ij8.1 | 4gqq.1 | 4gqr.1 | 4w93.1 | 4x9y.1 | 5e0f.1 | 5emy.1 | 5kez.1 | 5u3a.1 | 5va9.1 | 5va9.2